vero
cell
attenu
porcin
epidem
diarrhea
viru
pedv
strain
distinguish
wildtyp
pedv
use
restrict
enzym
fragment
length
polymorph
rflp
cell
attenu
oral
intramuscularli
im
administ
lateterm
pregnant
sow
mortal
result
highli
virul
pedv
challeng
investig
passiv
immun
suckl
piglet
two
differ
group
mortal
rate
oral
group
lower
im
group
particular
concentr
iga
pedv
higher
piglet
sow
oral
group
compar
im
group
attenu
viru
remain
safe
even
three
backpassag
piglet
find
studi
support
theori
vero
cell
attenu
viru
may
appli
oral
vaccin
induc
specif
immun
lateterm
pregnant
sow
high
margin
protect
pedv
infect
porcin
epidem
diarrhea
viru
pedv
coronaviru
etiolog
enteropathogen
agent
swine
debouck
pensaert
ducatel
et
al
wood
viru
replic
differenti
enterocyt
cover
villi
small
intestin
lead
villou
atrophi
maladsorpt
debouck
pensaert
moon
ped
occur
swinerais
countri
europ
well
china
korea
japan
thu
econom
loss
diseas
seriou
everi
winter
countri
pensaert
saif
wesley
infect
associ
diarrheal
case
neonat
pig
korea
kweon
et
al
live
vaccin
ped
use
korea
japan
due
endem
natur
diseas
kweon
et
al
kadoi
et
al
efficaci
commerci
avail
vaccin
limit
field
condit
protect
immun
induc
insuffici
directli
attribut
attenu
strain
employ
intramuscular
im
rout
previou
studi
serial
vero
cell
passag
pedv
design
restrict
fragment
length
polymorph
rflp
pattern
distinct
wildtyp
pedv
test
pathogen
piglet
safeti
pregnant
sow
oral
inocul
song
et
al
investig
report
result
field
trial
compar
oral
versu
im
inocul
viru
pregnant
sow
protect
piglet
pedv
challeng
continu
vero
cell
line
atcc
maintain
aminimum
essenti
medium
amem
supplement
fetal
bovin
serum
penicillin
unit
ml
streptomycin
lgml
amphotericin
b
lg
ml
vero
cell
attenu
pedv
propag
describ
previous
hofmann
wyler
kweon
et
al
briefli
prior
viru
inocul
growth
medium
confluent
cell
cm
flask
falcon
usa
remov
cell
wash
three
time
phosphatebuff
salin
pb
ph
next
cell
flask
inocul
ml
viru
adsorpt
h
cell
incub
amem
supplement
yeast
extract
tryptos
phosphat
broth
lg
trypsin
challeng
ped
viru
prepar
small
intestin
suckl
pig
inocul
oral
field
isol
cell
attenu
intestin
homogen
vv
suspens
phosphatebuff
salin
pb
ph
suspens
mix
vortex
clarifi
centrifug
min
supernat
fraction
pass
lm
syring
filter
acrodisk
gelman
use
challeng
experi
five
commerci
farm
use
pedv
viru
field
trial
three
farm
outbreak
vaccin
ped
two
farm
histori
ped
mix
breed
pig
employ
studi
yorkshir
landrac
duroc
sow
farm
b
c
locat
kyungsang
chuchung
provinc
serolog
neg
ped
viru
neutral
antibodi
number
pregnant
sow
three
pedfre
commerci
farm
sow
farm
b
c
inocul
oral
group
intramuscularli
im
group
ml
passag
level
titer
tcid
ml
week
prior
farrow
second
inocul
equival
titer
viru
administ
week
sow
vaccin
viru
compris
control
group
pair
serum
sampl
inocul
collect
twoweek
interv
pair
sera
week
farrow
farrow
colostrum
deliveri
test
presenc
antibodi
pedv
use
elisa
report
previous
kweon
et
al
piglet
group
hous
mother
artifici
suppli
colostrum
milk
thirti
piglet
select
randomli
farrow
sow
vaccin
im
control
group
challeng
exposur
virul
pedv
piglet
group
challeng
oral
ml
wildtyp
pedv
viru
titer
determin
challeng
sera
piglet
collect
elisa
serum
neutral
sn
analysi
antibodi
pedv
nurs
pig
remov
sow
h
prior
challeng
ml
virul
pedv
previous
caus
mortal
old
pig
piglet
group
hous
pen
environment
control
build
fed
substitut
milk
clinic
sign
diarrhea
mortal
challeng
piglet
observ
day
antibodi
respons
pedv
examin
experiment
period
durat
pedv
shed
challeng
wildtyp
pedv
monitor
use
rtpcr
twentyfour
pregnant
sow
two
farm
e
inocul
oral
ml
viru
passag
level
contain
tcid
ml
week
prior
farrow
colostrum
sampl
collect
deliveri
farrow
sow
moreov
two
colostr
sampl
collect
control
sow
farm
within
h
parturit
serum
sampl
obtain
cranial
vena
cava
colostrum
sampl
obtain
manual
gland
pool
im
inject
iu
oxytocin
whey
obtain
colostr
sampl
use
sn
test
eight
piglet
select
randomli
farrow
sow
farm
e
challeng
use
similar
method
nonvaccin
sow
provid
sourc
control
pig
farm
b
c
control
piglet
yorkshir
landrac
duroc
farm
e
seroneg
pedv
sn
test
age
provid
yangsung
laboratori
anim
inc
yongin
korea
anim
experi
compli
current
law
korea
anim
care
treatment
conduct
accord
guidelin
establish
seoul
nation
univers
institut
anim
care
use
committe
antigen
prepar
describ
previous
minor
modif
kweon
et
al
oh
et
al
briefli
dilut
antigen
secondari
antibodi
adjust
optic
densiti
od
around
use
neg
porcin
sera
well
micropl
costar
coat
lg
protein
mm
carbon
buffer
ph
overnight
follow
block
rabbit
serum
gelatin
dilut
sampl
porcin
sera
colostrum
neg
porcin
sera
use
adjust
antigen
concentr
pb
tween
pbst
react
h
wash
time
pbst
collect
posit
neg
porcin
sera
describ
previous
react
plate
rewash
condit
incub
igg
iga
dilut
horseradish
peroxidas
hrp
label
antiporcin
igg
iga
kpl
h
plate
develop
abt
substrat
kpl
room
temperatur
min
reaction
termin
h
od
measur
nm
sampl
test
time
plate
triplic
minim
intraassay
variat
sn
test
perform
use
previous
publish
method
modif
kusanagi
et
al
hyperimmun
pedv
refer
serum
prepar
antibodi
free
pedvfre
pig
inocul
ml
pedv
strain
ml
serum
collect
week
postinocul
neg
refer
serum
also
obtain
mockinfect
pig
age
briefli
swine
sera
inactiv
min
store
use
twofold
dilut
serum
mix
pedv
tcid
ml
equal
volum
incub
h
subsequ
ml
virusserum
mixtur
transfer
vero
cell
monolay
tissu
cultur
plate
wash
twice
pb
adsorpt
h
inocula
discard
wash
twice
pb
next
mainten
medium
contain
trypsin
lgml
ad
well
plate
incub
day
sn
titer
express
reciproc
highest
serum
dilut
result
cytopath
effect
cpe
inhibit
fecal
sampl
group
collect
everi
day
cotton
swab
cotton
tip
stick
cm
long
per
pig
upto
day
postchalleng
pedv
identifi
presenc
gene
rtpcr
experi
kim
et
al
song
et
al
follow
primer
employ
amplif
pedv
forward
revers
size
amplifi
product
bp
posit
control
util
cellattenu
pedv
strain
provid
virolog
lab
nation
veterinari
research
quarantin
servic
korea
revers
primer
use
synthesi
complementari
dna
threestep
procedur
perform
thermal
cycler
perkinelm
appli
biosystem
inc
foster
citi
ca
sampl
amplifi
use
program
consist
incub
min
follow
five
cycl
denatur
anneal
extens
cycl
denatur
anneal
extens
ad
everi
cycl
complet
cycl
sampl
kept
min
cool
specif
pcr
evalu
use
sever
caus
agent
diarrhea
tgev
porcin
rotaviru
bovin
viral
diarrhea
viru
passag
passag
level
colostrumdepriv
pig
piglet
passag
report
previous
modif
welter
rflp
marker
stabil
assess
vivo
passag
level
colostrumdepriv
pig
employ
three
consecut
passag
pig
order
allow
one
pig
control
passag
day
pi
pig
sacrif
duodenum
jejunum
ileum
collect
gross
histopatholog
rtpcr
detect
viru
kim
et
al
prepar
inoculum
next
passag
wv
tissu
suspens
small
intestin
addit
prepar
ml
suspens
fed
oral
next
pig
passag
hindiii
xhoiispecif
restrict
pattern
rflp
marker
shed
viru
analyz
describ
result
express
mean
sd
least
two
independ
experi
data
immun
respons
sn
test
convert
log
use
statist
analysi
oneway
anova
use
sa
version
softwar
employ
multipl
comparison
valu
p
consid
statist
signific
iggspecif
elisa
result
reveal
signific
differ
od
valu
oand
iminocul
group
farm
b
howev
differ
od
valu
vaccin
control
group
evid
interestingli
igaspecif
elisa
signific
od
differ
observ
sera
oand
iminocul
group
deliveri
colostrum
fig
b
p
colostrum
sampl
farm
b
differ
od
valu
im
group
evid
group
im
group
moreov
od
valu
group
increas
consider
second
vaccin
fig
iggspecif
elisa
comparison
od
valu
obtain
serum
colostrum
correspond
sow
deliveri
disclos
slightli
higher
valu
colostrum
regardless
inocul
rout
interestingli
igaspecif
elisa
valu
group
significantli
increas
colostrum
compar
sera
contrast
major
differ
observ
two
sampl
type
colostrum
sera
im
group
furthermor
antibodi
respons
sow
sn
test
distinct
sampl
im
group
b
farm
fig
optic
densiti
od
valu
colostrum
sampl
pregnant
sow
farm
e
oral
inocul
celladapt
pedv
rang
colostrum
sampl
control
group
colostrum
sampl
mortal
piglet
challeng
wildtyp
pedv
oinocul
group
compar
control
group
contrast
piglet
mortal
iminocul
group
antibodi
respons
piglet
challeng
present
fig
piglet
deliv
oinocul
sow
display
higher
concentr
iga
sn
titer
imdeliv
sow
p
howev
signific
differ
igg
level
observ
piglet
oand
iminocul
group
signific
differ
viru
shed
oand
iminocul
group
viru
shed
ogroup
last
day
challeng
im
group
shed
last
day
challeng
howev
endpoint
viru
shed
control
group
detect
due
mortal
day
postchalleng
first
passag
viru
shed
last
day
similar
data
shown
tabl
second
passag
durat
viru
shed
decreas
day
last
day
third
passag
tabl
rflp
marker
inoculum
maintain
passag
identifi
restrict
enzym
pattern
hindiii
xhoii
three
consecut
passag
inocul
pig
remain
clinic
histopatholog
normal
villou
atrophi
moreov
revers
virul
observ
passag
examin
immunoprophylact
effect
pregnant
sow
oral
inocul
disclos
decreas
mortal
piglet
vaccin
anim
indic
celladapt
induc
immun
statu
previous
protect
immun
induc
attenu
strain
pedv
inocul
intramuscularli
kweon
et
al
pedv
isol
serial
passag
vero
cell
cultur
differenti
wildtyp
strainus
rtpcr
rflp
hindiii
xhoii
enzym
song
et
al
moreov
attenu
safeti
pedv
passag
level
oral
inocul
report
song
et
al
sinc
lactogen
immun
protect
suckl
pig
pedv
infect
induct
mucos
immun
respons
lactat
pig
may
effect
way
protect
efficaci
studi
similar
enter
diseas
bovin
coronaviru
reveal
modifi
live
oral
vaccin
significantli
protect
calv
highli
virul
challeng
newborn
calf
diarrheal
coronaviru
isol
welter
highli
attenu
pedv
oral
inocul
confer
partial
protect
challeng
virul
viru
convent
pig
protect
relat
inocul
dose
enhanc
increas
concentr
de
arriba
et
al
studi
compar
efficaci
celladapt
inocul
via
oral
intramuscular
im
rout
use
sn
test
elisa
discrep
data
obtain
elisa
sn
test
experiment
condit
possibl
due
addit
trypsin
requir
pedv
propag
degrad
antibodi
bae
et
al
correl
sn
titer
elisa
describ
previous
oh
fig
antibodi
respons
serum
sampl
porcin
epidem
diarrhea
viru
piglet
use
igg
igaspecif
elisa
challeng
exposur
p
fig
antibodi
respons
serum
sampl
porcin
epidem
diarrhea
viru
piglet
use
sn
test
challeng
exposur
p
b
control
b
control
control
pedv
detect
fece
use
rtpcrrflp
pattern
hindiii
andxhoii
viru
b
pig
sacrif
day
oral
inocul
small
intestin
collect
prepar
next
oral
inoculum
et
al
briefli
maximum
agreement
obtain
serum
sampl
p
sn
titer
howev
least
sampl
sn
titer
elisa
shown
detect
igg
includ
matern
antibodi
low
level
contrast
sn
test
detect
igm
igg
antibodi
sn
test
detect
matern
antibodi
titer
drop
level
difficult
interpret
possibl
nonspecif
reaction
interfer
test
protect
effect
observ
high
titer
iga
sn
matern
colostrum
consist
find
report
high
titer
passiv
serum
antibodi
colostrumf
convent
piglet
associ
reduc
mortal
follow
inocul
virul
virus
differ
mortal
im
inocul
group
may
due
iga
content
colostrum
fact
iga
concentr
challeng
exposur
piglet
deliv
oinocul
group
higher
iminocul
group
result
indic
iga
play
central
role
prevent
ped
igg
moreov
strong
correl
iga
concentr
detect
blood
gut
associ
lymphoid
tissu
de
arriba
et
al
similarli
yuan
et
al
report
pig
oral
inocul
rotaviru
iga
antibodi
secret
respons
blood
analog
gut
piglet
extent
protect
pedv
base
presenc
specif
iga
antibodi
milk
immun
sow
de
arriba
et
al
antigen
sensit
gut
iga
immunocyt
migrat
mammari
gland
local
secret
iga
antibodi
colostrum
milk
gut
mammari
immunolog
axi
import
concept
design
optim
vaccin
provid
effect
lactogen
immun
saif
et
al
sow
immun
infect
pedv
protect
suckl
pig
lactogen
immun
pensaert
et
al
viru
specif
antigen
stimul
lymphocyt
occur
intestin
infect
sow
stimul
cell
subsequ
circul
bodi
matur
plasma
cell
migrat
gut
settl
organ
mammari
gland
secretori
iga
product
occur
site
lactogen
igaproduc
cell
thu
stimul
intestin
produc
iga
mammari
gland
pig
regularli
suckl
immun
mother
constantli
provid
milkbound
iga
antibodi
lumen
passiv
immun
relat
presenc
specif
viru
neutral
antibodi
gastrointestin
tract
suckl
pig
igg
account
ig
colostrum
howev
iga
effect
neutral
oral
infect
pathogen
igg
igm
iga
resist
proteolyt
degrad
intestin
tract
viru
neutral
abil
igg
igm
offit
clark
accordingli
perform
igaspecif
elisa
elucid
relationship
protect
iga
content
colostrum
notabl
variabl
piglet
immun
observ
accord
degre
colostrum
uptak
litter
size
antibodi
uptak
qualiti
colostrum
song
et
al
determin
specif
role
iga
igg
prevent
ped
vaccin
chang
antibodi
concentr
milk
lactat
requir
investig
durat
viru
shed
virul
challeng
indic
protect
level
yuan
et
al
ward
et
al
three
farm
select
investig
pedvfre
piglet
farm
shed
pedv
challeng
therefor
viru
shed
challeng
exposur
possibl
inoculum
rflp
marker
earlier
studi
report
complet
protect
pedv
infect
prevent
viru
shed
challeng
exposur
de
arriba
et
al
high
titer
serum
antibodi
piglet
relat
reduc
sever
durat
diarrhea
shorter
period
viru
shed
accordingli
viru
shed
piglet
assess
challeng
use
rtpcr
signific
differ
durat
viru
shed
observ
im
group
pedv
shed
may
variabl
depend
sensit
detect
tool
moreov
shed
may
influenc
viral
strain
employ
case
cell
attenu
viru
shed
last
day
sow
day
comparison
durat
viru
shed
vaccin
control
group
perform
due
death
control
piglet
day
postchalleng
result
indic
passiv
immun
pedv
prevent
viru
shed
challeng
addit
studi
revers
virul
conduct
serial
pig
passag
celladapt
pedv
remain
safe
even
three
passag
colostrumdepriv
pig
accordingli
propos
celladapt
may
appli
vaccin
candid
commerci
farm
condit
although
rise
concern
possibl
confound
factor
introduc
genet
variat
hous
variabl
hoblet
et
al
conclus
celladapt
pedv
prevent
mortal
challeng
induc
higher
iga
concentr
colostrum
elev
iga
concentr
may
explain
reduc
mortal
oinocul
group
compar
iminocul
control
group
experi
includ
lymphoprolif
respons
antibodysecret
cell
lymphoid
tissu
pig
challeng
requir
improv
pedv
immun
pig
